A Phase 3 Studyof Pembrolizumab in Combination with Carboplatin/Taxane (Paclitaxel or Nab-paclitaxel) Followed by Pembrolizumab with or without Maintenance Olaparib in the First-line Treatment of Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Yazıcı O. (Executive), Özdemir N., Kurt İnci B., Gürler F.
Other International Funding Programs, 2019 - 2021
-
Project Type:
Other International Funding Programs
-
Begin Date:
January 2019
-
End Date:
March 2021